Pharmacokinetics of Cefepime and AAI101 in Subjects With Renal Insufficiency and Healthy Subjects

  • STATUS
    Not Recruiting
  • participants needed
    30
  • sponsor
    Allecra
Updated on 22 January 2021
Investigator
Felix Muehr-Wilkenshoff, MD
Primary Contact
Pharmaceutical Research Associates CZ, s.r.o. (1.7 mi away) Contact

Summary

This is a Phase 1, multi-center, open-label, PK and safety study of a single dose of AAI101 in combination with cefepime in male and female subjects with mild renal impairment (Group 1, n = 6), moderate renal impairment (Group 2, n = 6), severe renal impairment (Group 3, n = 6), ESRD requiring dialysis (Group 4, n = 6), and normal renal function (Group 5, n = 6) as defined using the estimated value for creatinine clearance (CLcr) at Screening.

The study consists of a 28-day screening period, followed by a single dose administration of AAI101 in combination with cefepime antibiotic on Day 1, an in house period (assessment period) and follow-up visit. All subjects will be confined to the study site from Day -1 (the day before dosing) until the morning of Day 3. The follow-up visits will occur on Day 7 (2 days), on Day 14 (2 days), and on Day 30 (2 days), if the results of the safety hepatic assessments are abnormal on Day 14 (2 days).

Group 4 (ESRD requiring dialysis) will have 2 in-house periods (separated by at least 7 days), and will receive the single doses of AAI101 in combination with cefepime antibiotic once after dialysis and once before dialysis. The follow-up visit for Group 4 will occur on Day 7 (2 days), on Day 14 (2 days), and on Day 30 (2 days), if the results of the safety hepatic assessments are abnormal on Day 14 (2 days), counting from Day 1 of the second period.

Details
Condition PK in Patients With Various Degrees of Renal Disease, PK in Patients With Various Degrees of Renal Impairment
Treatment cefepime/AAI101
Clinical Study IdentifierNCT03680352
SponsorAllecra
Last Modified on22 January 2021

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note